Fresenius Group Overview
- The Health Care Group
-
Stories
-
![]()
Crucial lessons learned
-
![]()
More ‘Quality of Life’ in clinics
-
![]()
Ready to help the littlest ones
-
![]()
Fresenius Medical Care celebrates first 20 years
-
![]()
Making mistakes to avoid them
-
![]()
A vast island nation
-
![]()
"I want to help others, so they won’t give up"
-
![]()
17,962 miles halfway around the world
-
![]()
A polyclinic in Ghana
-
![]()
Dialysis patient succeeds in giving birth
-
![]()
The future is purple
-
![]()
From a local pharmacy to a global corporation
-
- Investors
-
Media
![]()
Contact
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com - Careers
Crucial lessons learned
More ‘Quality of Life’ in clinics
Ready to help the littlest ones
Fresenius Medical Care celebrates first 20 years
Making mistakes to avoid them
A vast island nation
"I want to help others, so they won’t give up"
17,962 miles halfway around the world 
A polyclinic in Ghana
Dialysis patient succeeds in giving birth
The future is purple
From a local pharmacy to a global corporation
-
Lifesaver dialysis
More than 3 million people worldwide need to regularly undergo this vital blood-cleansing procedure. But how does it work? You can quickly find out in our explanatory video!
Watch the explanatory video -
Crucial lessons learned
Faced with one of the ‘superbugs’ that pose a huge health threat worldwide, Fresenius Helios turned to advanced hygiene management.
Read the story -
More ‘Quality of Life’ in clinics
Fresenius Medical Care Argentina patients enjoy fitness and therapy activities during treatments.
Read the story -
Ready to help the littlest ones
Some children have to fight for life, right from birth: A day on the Neonatology ward of HELIOS Hospital Schwerin, Germany.
Read the story
News
- Brief News
2018 DRG inflator for German hospitals set at 2.97%
The price increase for hospital services in Germany has been set at 2.97% for 2018. This is in line with the level of past years.
September 15, 2017Fresenius Helios
Brief NewsFresenius Medical Care expands production site in Malaysia
Fresenius Medical Care has expanded its regional manufacturing plant in Bandar Enstek, Malaysia. Dato' Seri Dr. Chen Chaw Min, Secretary General of the Malaysian Ministry of Health graced the opening ceremony. The plant is a state-of-the-art facility and will be Fresenius Medical Care's regional manufacturing hub for Southeast Asia. In addition to supplying high-quality hemodialysis concentrates and disinfectants, the plant produces peritoneal dialysis (PD) products necessary for advanced continuous ambulatory PD treatment.
September 15, 2017Fresenius Medical Care
-
![]()
![]()
- Brief News
Fresenius refinances Credit Agreement successfully – S&P rates bonds now investment grade
The amended 2013 Credit Agreement streamlines Fresenius’ financing structure by replacing the existing senior secured facilities with unsecured facilities. Concurrently, the guarantor structure was aligned, with Fresenius SE & Co KGaA now being sole guarantor. The Credit Agreement has an aggregate amount of approximately €3.8 billion and consists of revolving facilities and term loans with maturities in 2021 and 2022. The transaction was well received by investors and substantially oversubscribed. On the basis of the unsecured structure and consistent with the corporate credit rating of Fresenius, S&P has raised the rating of the Fresenius bonds to BBB- from BB+.
August 24, 2017Fresenius
Brief NewsFresenius Helios invests in German hospital network
Fresenius Helios continues to invest in the expansion and modernization of its hospitals and clinics. HELIOS Clinic Geesthacht, located just east of Hamburg, has opened an extension with 20 additional neurological rehabilitation places for young people. The investment in the specialist clinic for neurology and neurological rehabilitation is €4.6 million. In the state of Saxony, meanwhile, work has started on a new building for the emergency ward at HELIOS Hospital Leisnig. This €3.3 million project is scheduled for completion in autumn 2018.
August 22, 2017Fresenius Helios
-
![]()
![]()
-
![]()
![]()
-
![]()
Brief NewsFresenius Helios expands hospital near Berlin
Fresenius Helios is investing more than €18 million to expand the company’s hospital in the German town of Bad Saarow, about 25 kilometers (15 miles) east of Berlin. The project at HELIOS Hospital Bad Saarow includes construction of a new building that will add bed capacity to meet growing demand, and an expansion of the radiology department. The construction is scheduled for completion in spring 2019.
July 20, 2017Fresenius Helios
-
![]()
Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule
July 12, 2017Fresenius Medical Care
-
![]()
Brief NewsFresenius wins award for Quirónsalud acquisition
Fresenius was presented yesterday with the Corporate Finance Award for the company's acquisition of Quirónsalud, Spain’s largest private hospital operator. The award is given annually by the major German business daily Börsen-Zeitung for transactions judged to be outstanding in both strategical and financial terms. Fresenius won in the Large Caps category, which groups major companies. With the Quirónsalud acquisition, the Börsen-Zeitung said, “Fresenius succeeded in making a quantum leap in the hospital business."
June 23, 2017Fresenius
-
![]()
![]()
- Brief News
Fresenius Helios opens new hospital facility in northern Germany
HELIOS Hospital Wesermarsch has gone into operation in a newly built facility in the northern German town of Nordenham. The new hospital building has 120 patient beds, three operating rooms and a hybrid cardiac catheterization lab. Capacity can be increased to 235 beds, if needed. Fresenius Helios invested €36 million in the facility, which took about three years to build, with the County of Wesermarsch contributing an additional €10 million.
May 22, 2017Fresenius Helios
![]()
-
![]()
![]()
-
![]()
![]()
- Brief News
Fresenius' Investment Grade Rating remains unaffected
Following Fresenius’ announcement to acquire Akorn, Inc. and Merck KGaA’s biosimilars business, the rating agencies Standard & Poor’s (BBB-, stable), Moody’s (Baa3, stable) and Fitch (BBB-, stable) confirm the corporate credit ratings of Fresenius to be unaffected.
April 26, 2017Fresenius
![]()
- Brief News
Fresenius Kabi USA wins supplier award from Vizient
Fresenius Kabi USA has won the prestigious 2016 Pharmaceutical Supplier of the Year Award from Vizient Inc., the largest group purchasing organization for U.S. academic medical centers, community hospitals, pediatric facilities, integrated health delivery networks and non-acute health care providers. Fresenius Kabi has won six Vizient awards for service excellence in recent years.
April 24, 2017Fresenius Kabi
Brief NewsFresenius Vamed wins contract for university hospital building in Austria
Fresenius Vamed will realize a 350-bed building at University Hospital St. Pölten, in Austria. Working with a partner company, Fresenius Vamed will be the general contractor on the €176 million project. The new building will have some 21,000 square meters (226,000 square feet) of floor space, housing a range of specialist wards. Construction is scheduled to begin in 2019.
April 21, 2017Fresenius Vamed
- Brief News
Fresenius Helios modernizing hospital in central Germany
Fresenius Helios is investing €14 million to modernize its hospital in Wipperfürth, North Rhine-Westphalia. Starting late this month, two wards will be completely renovated and expanded, with three delivery rooms to follow. To minimize disruptions to hospital operations, the individual renovations are being carried out in sequence. When completed in early 2019, they will provide more comfort for patients and reduce the distances that need to be walked inside the hospital.
April 06, 2017Fresenius Helios
Brief NewsFitch rates Fresenius Finance Ireland Bonds at BBB- and affirms Fresenius at BBB-
Fitch Ratings has assigned Fresenius Finance Ireland’s €2,600 million notes issued to finance the acquisition of Quirónsalud an instrument rating of BBB-. It also affirmed Fresenius’ corporate credit rating at BBB-. The outlook is stable. The €2,600 million notes were drawn under the newly established Fresenius European Medium Term Note (EMTN) Program and issued by Fresenius Finance Ireland plc., a wholly owned subsidiary of Fresenius SE & Co. KGaA.
March 23, 2017Fresenius
-
![]()
Import (ICS)November 02, 2017 | Bad Homburg, Germany
Conference Call Q3 2017, Fresenius
Live Webcast
Social Media
Library
-
![]()
Annual Report 2016 (US-GAAP) (PDF, 2.89 MB)
-
![]()
Fresenius "At a Glance" (PDF, 344 KB)
-
![]()
Book "100 Years of Fresenius" (PDF, 6.25 MB)
-
![]()
Fresenius Factsheet H1/2017 (PDF, 459 KB)
-
![]()
Fresenius Medical Care "Profile" (PDF, 368 KB)
-
![]()
Fresenius Medical Care Magazine "Living Knowledge" (PDF, 2.66 MB)
-
![]()
Social Media Guidelines (PDF, 1.97 MB)
-
![]()
Investor Relations General Presentation (PDF, 832 KB)
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
Contact
